Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × peginterferon alfa-2b × Clear all

NCT00085384 2012-08-02

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms